PHP
CARL

Parkman Healthcare Partners’s Carlsmed CARL Stock Holding History

Parkman Healthcare Partners’s Portfolio CARL Stock Details CARL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.2M Buy
597,318
+76,195
+15% +$801K 0.63% 53
2026
Q1 		$4.72M Buy
+521,123
New +$6.3M 0.49% 61

Other funds holding CARL

JT
Jupiter Topco New York $245B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
KC
KCM Capital Shawnee, Kansas $618M AUM
PC
Pier Capital Stamford, Connecticut $755M AUM 94.38% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
PWM
Palumbo Wealth Management Great Neck, New York $478M AUM 50.95% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
SSA
Schonfeld Strategic Advisors New York $27.9B AUM 51.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return

Parkman Healthcare Partners's CARL Position: Q2 2026 in Review

Parkman Healthcare Partners increased its Carlsmed (CARL) stake by 15% in Q2 2026, buying an estimated $801K and bringing the position to 597,318 shares worth $6.2M. The position accounts for 0.63% of the portfolio, ranked #53.

Parkman Healthcare Partners first reported a position in CARL in Q1 2026 and has held it in 2 quarters since. 74 funds tracked by Wall St. Rank hold CARL as of Q2 2026.

  • Parkman Healthcare Partners held 597,318 shares of Carlsmed worth $6.2M as of Q2 2026.
  • Parkman Healthcare Partners bought 76,195 Carlsmed shares in Q2 2026, an estimated $801K.
  • Carlsmed made up 0.63% of Parkman Healthcare Partners's portfolio in Q2 2026, its #53 holding.
  • Parkman Healthcare Partners first reported a position in Carlsmed in Q1 2026 and has held it in 2 quarters since.
  • 74 funds tracked by Wall St. Rank held Carlsmed as of Q2 2026.

Based on Parkman Healthcare Partners's 13F filing for Q2 2026, filed 14 Aug 2026.